Malaria Medicine for Infants Approved: Coartem Baby Gets Swissmedic Nod for Newborn Treatment
Malaria medicine for infants approved by Swissmedic! Coartem Baby becomes the first antimalarial drug for newborns, targeting babies weighing 2–5 kg. Essential update for government exam aspirants. 🌍 Switzerland Clears First Malaria Medicine for Small Babies Overview of the Breakthrough On July 9, 2025, Swissmedic, Switzerland’s medical regulatory authority, granted approval for Coartem Baby (also…
